Home > Business > PTI > Report

Ranbaxy gets FDA nod for hypertension drug

April 26, 2004 17:23 IST

Ranbaxy Laboratories Ltd has received the US Food and Drug Administration's approval to market Fosinopril sodium tablets in the United States.

The USFDA website on Monday said that the company had been given the go-ahead for marketing Fosinopril sodium indicated for the treatment of hypertension.


Article Tools
Email this article
Top emailed links
Print this article
Write us a letter
Discuss this article



Related Stories


Veronica, SRL Ranbaxy in pact



People Who Read This Also Read


Brand India on PM's mind

BPO: India to see R&D boom








© Copyright 2004 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.











Copyright © 2004 rediff.com India Limited. All Rights Reserved.